The Roles of CCR9/CCL25 in Inflammation and Inflammation-Associated Diseases

Chemokine is a structure-related protein with a relatively small molecular weight, which can target cells to chemotaxis and promote inflammatory response. Inflammation plays an important role in aging. C-C chemokine receptor 9 (CCR9) and its ligand C-C chemokine ligand 25 (CCL25) are involved in the...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cell and developmental biology 2021-08, Vol.9, p.686548-686548
Main Authors: Wu, Xue, Sun, Meng, Yang, Zhi, Lu, Chenxi, Wang, Qiang, Wang, Haiying, Deng, Chao, Liu, Yonglin, Yang, Yang
Format: Article
Language:English
Subjects:
autoimmune
CCL25
CCR9
Cell and Developmental Biology
chemokine
inflammatory disease
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chemokine is a structure-related protein with a relatively small molecular weight, which can target cells to chemotaxis and promote inflammatory response. Inflammation plays an important role in aging. C-C chemokine receptor 9 (CCR9) and its ligand C-C chemokine ligand 25 (CCL25) are involved in the regulating the occurrence and development of various diseases, which has become a research hotspot. Early research analysis of CCR9-deficient mouse models also confirmed various physiological functions of this chemokine in inflammatory responses. Moreover, CCR9/CCL25 has been shown to play an important role in a variety of inflammation-related diseases, such as cardiovascular disease (CVD), rheumatoid arthritis, hepatitis, inflammatory bowel disease, asthma, etc. Therefore, the purpose of this review gives an overview of the recent advances in understanding the roles of CCR9/CCL25 in inflammation and inflammation-associated diseases, which will contribute to the design of future experimental studies on the potential of CCR9/CCL25 and advance the research of CCR9/CCL25 as pharmacological inflammatory targets.
ISSN:2296-634X
2296-634X
DOI:10.3389/fcell.2021.686548